Removal of contaminating TEM-la beta-lactamase gene from commercial Taq DNA polymerase.

Department of Biological Sciences, Myongji University, San 38-2 Namdong, Yongin, Gyeonggido 449-728, Republic of Korea.
The Journal of Microbiology (Impact Factor: 1.44). 03/2006; 44(1):126-8.
Source: PubMed


This study confirms that Taq DNA polymerase could be contaminated with the blaTEM-1(a) gene. It also proposes two different methods that could be used to overcome DNA contamination: (i) DNase I treatment prior to PCR amplification; and (ii) the use of a highly purified Taq DNA polymerase which was devoid of detectable contamination.

Download full-text


Available from: Sang Hee Lee, Sep 29, 2015
29 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: PCR detection of microbial pathogens in blood from patients is a promising issue for rapid diagnosis of sepsis and early targeted therapy. However, for PCR assays detecting all bacterial groups, broad range primers, in particular the 16S rDNA targeting primers have to be used. Upcoming false signals and reduced sensitivity are a common problem as a consequence of unspecific amplification reactions with the human DNA background. Here we show that, using total DNA extracts from blood, unspecific signals occurred in general 16S rDNA PCRs as a result of the amplification of human sequences. To address this problem, we developed a protocol by which the human background DNA is removed and bacterial DNA is enriched during sample preparation, a method we termed background-free enrichment method (BFEM). In general, we aimed to exclude false signals due to the human background DNA yielded from 16S rDNA PCR, Real-Time-PCR and IGS-PCR analyses. We applied the BFEM to the analysis of blood samples from 22 patients and obtained results similar to standard blood culture methods. The BFEM allows specific and sensitive detection of pathogens in downstream PCR assays and is easy to handle due to the quick sample preparation procedure. Thus, the BFEM contributes to the generation of replicable and more reliable data in general 16S rDNA PCR assays.
    Comparative immunology, microbiology and infectious diseases 03/2008; 32(3):207-19. DOI:10.1016/j.cimid.2007.10.005 · 2.02 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Antibiotic-resistant pathogens are profoundly important to human health, but the environmental reservoirs of resistance determinants are poorly understood. The origins of antibiotic resistance in the environment is relevant to human health because of the increasing importance of zoonotic diseases as well as the need for predicting emerging resistant pathogens. This Review explores the presence and spread of antibiotic resistance in non-agricultural, non-clinical environments and demonstrates the need for more intensive investigation on this subject.
    Nature Reviews Microbiology 03/2010; 8(4):251-9. DOI:10.1038/nrmicro2312 · 23.57 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to assess the performance of seven French laboratories for 16S rDNA detection by real-time PCR in the diagnosis of BJI (bone and joint infection) to validate a large multicenter study. External quality control (QC) was required owing to the differences in extraction procedures and the molecular equipment used in the different laboratories. Three proficiency sets were organized, including four bacterial DNA extracts and four beadmill-pretreated osteoarticular specimens. Extraction volumes, 16S rDNA primers and sequencing interpretation rules were standardized. In order to assess the each laboratory's ability to achieve the best results, scores were assigned and each QC series was classified as "optimal", "acceptable" or "to be improved". One hundred-sixty-eight QCs were sent and 160 responses were analyzed. Expected results were obtained for 93.8% with the same proportion for extracts (75/80) and clinical specimens (75/80). For the specimens, there was no significant difference between manual and automated extraction. This QC demonstrated the ability to achieve good and homogeneous results using the same 16S rDNA PCR with different equipment, and validates the possibility of high-quality multicenter studies using molecular diagnosis for BJI. Copyright © 2014, American Society for Microbiology. All Rights Reserved.
    Journal of Clinical Microbiology 11/2014; 53(2). DOI:10.1128/JCM.02413-14 · 3.99 Impact Factor